Loading clinical trials...
Loading clinical trials...
SUSTAIN (Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group tria...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Axsome Therapeutics, Inc.
NCT06288568 · Obesity, Shift-work Disorder, and more
NCT06492109 · Sleep Deprivation, Aging, and more
NCT05633498 · Shift-work Disorder
NCT07394283 · Shift-work Disorder
NCT05186233 · Shift-work Disorder
Clinical Research Site
Cullman, Alabama
Clinical Research Site
Chandler, Arizona
Clinical Research Site
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions